Creative Medical Technology Holdings, Inc. Common Stock
2.27
USD
Patrocinado
-0.18
-7.35%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
2.31
+0.04
+1.98%
Informes de beneficios de CELZ
Ratio de Sorpresa Positivo
CELZ superó 7 de las últimas 16 estimaciones.
44%
Próximo informe
Fecha del próximo informe
12 mar 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
-$0.37
Cambio implícito desdeQ3 25(Revenue/ EPS)
--
/
-22.92%
Cambio implícito desdeQ4 24(Revenue/ EPS)
-100.00%
/
-66.96%
Creative Medical Technology Holdings, Inc. Common Stock earnings per share and revenue
On 07 nov 2025, CELZ reported earnings of -0.48 USD per share (EPS) for Q3 25, beating the estimate of -0.48 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an reducir of -22.92% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were Creative Medical Technology Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Creative Medical Technology Holdings, Inc. Common Stock reported EPS of -$0.48, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Creative Medical Technology Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 8.61%, changed from $3.02 before the earnings release to $3.28 the day after.
When is Creative Medical Technology Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for 12 mar 2026.
What are the forecasts for Creative Medical Technology Holdings, Inc. Common Stock's next earnings report?
Based on 3
analistas, Creative Medical Technology Holdings, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q4 2025.